Peri-Implantitis Treatment Market Share

  • Report ID: 3922
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Peri-Implantitis Treatment Market Share

APAC Market Statistics

The Asia Pacific peri-implantitis treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. The growth of the market can be attributed majorly to the increasing prevalence of oral diseases, along with rising awareness regarding oral health. In several Asian countries, people do not give the necessary attention to their oral health and prefer traditional methods to cure the oral disease which results in a high number of people suffering from these diseases and the need for proper treatment. For instance, in the South Asia region, more than 875 million untreated dental caries cases were diagnosed in 2019. Hence, higher demand for oral care products appears in the Asia Pacific region where the regional oral care segment is estimated to reach approximately USD 20 billion by 2027. Hence, such factors are anticipated to expand the market size over the forecast period.

North American Market Forecast   

The North America peri-implantitis treatment market, amongst the market in all the other regions, is projected to hold the second largest share during the forecast period. The growth of the market can be attributed majorly to growing incidences of oral diseases in the region backed by the higher consumption of tobacco and alcohol. In this region, people are observed to consume alcohol and tobacco from an early age which results in damage to their teeth. As per the data by the Centers for Disease Control and Prevention (CDC), 46% of all adults, aged 30 years or older, suffer from some kind of gum disease while 9% of adults are affected by severe gum diseases. Furthermore, the growing geriatric population with a higher need for dental implants and treatment for better oral health is also anticipated to boost the market growth over the forecast period.

Research Nester
Peri-Implantitis-Treatment-Market-Regional
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3922
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of peri-implantitis treatment is evaluated at USD 2.31 Billion.

The peri-implantitis treatment market size was valued at USD 2.16 Billion in 2023 and is likely to exceed USD 5.72 Billion by the end of 2036, registering over 7.8% CAGR during the forecast period i.e., between 2024-2036. Growing consumption of cigarettes and increasing awareness of oral care are the major factors driving the market growth.

Asia Pacific is expected to dominate majority industry share by 2036, attributed to increasing prevalence of oral diseases, along with rising awareness regarding oral health.

Aetna Inc., Pfizer Inc., Cadila Pharmaceuticals Limited, R N Laboratories Pvt Ltd, Neoss Limited, Basic Pharma Lifesciences Pvt Ltd, Dawood and Tanner, Prachi Pharmaceuticals Private Limited, Geistlich Pharma AG., Healthy Life Pharma Private Limited.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample